文献速递烧伤瘢痕与激光

加巴喷丁与普瑞巴林用于烧伤后瘙痒及神经病理性疼痛的回顾性病历分析

Use of gabapentin and pregabalin for pruritus and neuropathic pain associated with major burn injury: A retrospective chart review.
PubMed 文献 · Burns · 2017-08-16

该回顾性病历分析纳入136例≤20岁烧伤幸存者,评估加巴喷丁和/或普瑞巴林对瘙痒及神经病理性疼痛的疗效与安全性。结果显示多数患者有效,仅少数出现需调整或停药的不良反应,部分患者可两药联用。

要点

  • 加巴喷丁对单纯瘙痒有效率91.4%,对单纯神经痛100%,对两者并存43.3%。
  • 两药联用对瘙痒有效率100%,对瘙痒合并疼痛有效率88.2%。
  • 普瑞巴林均在加巴喷丁疗效不足后加用,不良反应少且多可耐受。

核心结论

  • 加巴喷丁和普瑞巴林对多数烧伤幸存者的瘙痒和神经病理性疼痛有效,部分患者可两药联用且不良反应少。

研究设计与样本

  • 回顾性病历与药房记录分析,纳入≤20岁接受加巴喷丁和/或普瑞巴林的烧伤幸存者136例。

主要发现

  • 112例单用加巴喷丁,24例两药联用,无单用普瑞巴林者;104例仅有瘙痒,2例仅有神经痛,30例两者均有。
  • 加巴喷丁平均有效剂量:≤5岁23.9±10.3mg/kg/天,6-12岁27.0±15.3mg/kg/天,>12岁34.1±15.7mg/kg/天。
  • 普瑞巴林平均有效剂量:6-12岁6.5±3.5mg/kg/天,>12岁4.7±1.6mg/kg/天;1例5岁患儿用3.7mg/kg/天。
  • 联用者中加巴喷丁因瘙痒无效的最大剂量为32.8±18.0mg/kg/天,因瘙痒和疼痛无效为28.1±18.3mg/kg/天。
  • 单用加巴喷丁者瘙痒有效91.4%、神经痛有效100%、两者并存有效43.3%;联用者瘙痒有效100%、两者并存有效88.2%。

临床怎么用

  • 对烧伤后瘙痒或神经病理性疼痛的儿童及青少年,可考虑加巴喷丁或普瑞巴林,并依据年龄调整剂量。
  • 普瑞巴林可在加巴喷丁疗效不足时加用,联用对瘙痒及瘙痒合并疼痛有效率高。
  • 用药期间监测镇静、多动、恶心呕吐等不良反应,轻微者可调整剂量继续用药。

局限性

  • 回顾性设计,样本量有限,普瑞巴林均在加巴喷丁疗效不足后使用,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Pruritis after burn is one of the most common chronic complaints in burn survivors. Pruritus is often indistinguishable from neuropathic pain. There is a paucity of studies reporting the use of gabapentin and pregabalin to treat both pruritus and neuropathic pain. The purpose of this current study is to explore and document the effect of gabapentin and pregabalin in children and adolescent burn survivors. METHODS: A retrospective review of charts and pharmacy records of gabapentin and pregabalin dispensed to control pruritus and/or pain was conducted for burn survivors up to 20 years of age. Data collected included medication doses, age and weight of patients, presence of neuropathic pain and pruritus, reported response to medication, and side effects of these medications. 136 individuals who received gabapentin, pregabalin, or both medications are included in the study. 112 received only gabapentin, none received only pregabalin, and 24 received both. All results are documented in mean±standard deviation (s.d.) dose/kg/day. 104 individuals experienced pruritus exclusively, two experienced neuropathic pain exclusively, and 30 experienced both. Use of medications was considered effective if the individuals reported pruritus or pain relief from the medication. The medication was considered safe if the individuals did not experience adverse side effects warranting discontinuation of the drugs. Medications were continued with dose adjustments if an individual reported minor side effects such as sedation or hyperactivity. RESULTS: The average effective dose mg/kg/day for gabapentin and pregabalin was calculated for each of the three age groups (≤5years, 6-12 years, and >12years). The average effective dose of gabapentin was 23.9±10.3mg/kg/day for children ≤5years, 27.0±15.3mg/kg/day for children 6-12 years, and 34.1±15.7mg/kg/day for children >12years. The average effective dose of pregabalin was 6.5±3.5mg/kg/day for children 6-12 years and 4.7±1.6mg/kg/day for children >12years. One 5-year-old child received 3.7mg/kg/day of pregabalin. Note that for all patients in this study, pregabalin was added after an inadequate response to gabapentin. For individuals receiving both gabapentin and pregabalin, the maximum gabapentin failure dose for pruritus was 32.8±18.0mg/kg/day and for both pain and pruritus was 28.1±18.3mg/kg/day. For individuals treated with only gabapentin, 91.4% had an adequate response for pruritus, 100% for neuropathic pain, and 43.3% for both pruritus and pain. 100% of individuals treated with both gabapentin and pregabalin had an adequate response for pruritus and 88.2% had an adequate response for both pruritus and pain. Gabapentin was associated with hyperactivity in two individuals, and sedation in one individual. One individual reported nausea, vomiting, and headaches when taking both medications; this resolved when gabapentin was discontinued. One individual reported sedation while taking both medications. CONCLUSION: Gabapentin and pregabalin are effective in relieving pruritus and neuropathic pain in most burn survivors. In some instances, these medications can be given together. Few individuals reported side effects.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Kaul I, Amin A, Rosenberg M, et al. Use of gabapentin and pregabalin for pruritus and neuropathic pain associated with major burn injury: A retrospective chart review. Burns. 2017. PMID: 28822592. doi:10.1016/j.burns.2017.07.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。